UBS AM
ZLAB icon

UBS AM’s Zai Lab ZLAB Stock Holding History

UBS AM’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Hold
628
– – ﹤0.01% 3230
2026
Q1 		$11.8K Buy
628
+471
+300% +$8.73K ﹤0.01% 3272
2025
Q4 		$2.77K Buy
+157
New +$3.68K ﹤0.01% 3086
2025
Q3 		– Sell
-5,250
Closed -$184K – 2647
2025
Q2 		$184K Buy
5,250
+4,050
+338% +$133K ﹤0.01% 2569
2025
Q1 		$43.4K Sell
1,200
-55,914
-98% -$1.72M ﹤0.01% 2616
2024
Q4 		$1.5M Buy
57,114
+1,200
+2% +$33.3K ﹤0.01% 2180
2024
Q3 		$1.35M Hold
55,914
– – ﹤0.01% 2231
2024
Q2 		$969K Buy
55,914
+37,743
+208% +$664K ﹤0.01% 2381
2024
Q1 		$291K Buy
18,171
+4,705
+35% +$99.1K ﹤0.01% 2403
2023
Q4 		$368K Buy
13,466
+148
+1% +$3.91K ﹤0.01% 2386
2023
Q3 		$324K Sell
13,318
-444,980
-97% -$11.9M ﹤0.01% 2414
2023
Q2 		$15.2M Hold
458,298
– – 0.01% 831
2023
Q1 		$15.2M Buy
458,298
+41,965
+10% +$1.61M 0.01% 831
2022
Q4 		$12.8M Sell
416,333
-1,120
-0.3% -$35.3K 0.01% 853
2022
Q3 		$14.3M Buy
417,453
+2,121
+0.5% +$90.7K 0.01% 850
2022
Q2 		$14.4M Sell
415,332
-5,883
-1% -$207K 0.01% 832
2022
Q1 		$18.5M Sell
421,215
-12,889
-3% -$623K 0.01% 861
2021
Q4 		$27.3M Buy
434,104
+32,459
+8% +$2.75M 0.01% 818
2021
Q3 		$42.3M Buy
401,645
+18,435
+5% +$2.65M 0.02% 673
2021
Q2 		$67.8M Buy
383,210
+20,922
+6% +$3.37M 0.03% 560
2021
Q1 		$48.3M Buy
362,288
+2,825
+0.8% +$437K 0.02% 627
2020
Q4 		$48.6M Buy
359,463
+126,112
+54% +$12.8M 0.02% 623
2020
Q3 		$19.4M Buy
233,351
+75,286
+48% +$6.04M 0.01% 771
2020
Q2 		$13M Buy
158,065
+59,265
+60% +$4.01M 0.01% 849
2020
Q1 		$5.09M Buy
+98,800
New +$5.15M ﹤0.01% 1042

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS AM's ZLAB Position: Q2 2026 in Review

UBS AM held its Zai Lab (ZLAB) position steady in Q2 2026 at 628 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3230.

UBS AM first reported a position in ZLAB in Q1 2020 and has held it in 25 quarters since. The position peaked at $67.8M in Q2 2021. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • UBS AM held 628 shares of Zai Lab worth $11.9K as of Q2 2026.
  • UBS AM left its Zai Lab share count unchanged in Q2 2026.
  • Zai Lab made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3230 holding.
  • UBS AM first reported a position in Zai Lab in Q1 2020 and has held it in 25 quarters since.
  • UBS AM's Zai Lab position peaked at $67.8M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.